Treatment with rhGH, which promotes growth, is generally safe in children but is associated with pseudotumor cerebri [32], slipped capital femoral epiphysis [33], progression of scoliosis [34], and/or the development of GH antibodies [35]. This evidence concerns the gene GH1 and pseudotumor cerebri.